Related Experiment Video
Updated: Mar 17, 2026
Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Bidirectional Crosstalk Between Intestinal Epithelium and Immune Microenvironment in Inflammatory Bowel Disease:
Jinghan Shen1, Simin Du1, Yuyue Zhang1
1School and Hospital of Stomatology, Zunyi Medical University, Zunyi, Guizhou, People's Republic of China.
Abstract:
Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, is characterized by chronic mucosal inflammation driven by dysregulated interactions between intestinal epithelial cells (IECs) and immune components. This review systematically explores the dynamic interplay between epithelial barrier integrity and immune-microenvironmental regulation in IBD pathogenesis. We highlight the dual roles of innate immunity (neutrophils, macrophages, dendritic cells, and innate lymphoid cells) and adaptive immunity (Th1, Th17, and Treg cells) in orchestrating inflammatory cascades and mucosal repair. It also describes the interaction between microbial metabolites and the intestinal microenvironment.Key mechanisms include neutrophil extracellular trap (NET)-mediated epithelial damage, macrophage polarization modulated by ROS/NOX4 signaling, and IL-22/STAT3-driven epithelial regeneration. Additionally, we dissect the Wnt/β-catenin and bile acid-TGR5 (Takeda G-protein-coupled receptor 5) pathways in intestinal stem cell renewal. Emerging therapeutic strategies targeting epithelial-immune axes, such as anti-IL-23/IL-17 biologics and MSC-derived exosomes, are critically evaluated. By integrating recent advances in single-cell omics and preclinical models, this review underscores the necessity of precision medicine approaches to restore immune-epithelial homeostasis. This paper also introduces the current application of organoids-a novel emerging technology-in experimental research.Future research should prioritize spatial-temporal mapping of cellular interactions and leverage organoids to advance translational validation of dual-target therapies to bridge mechanistic insights into clinical practice.
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:23Renewal of Intestinal Stem Cells
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal